Venture capital firms incubate, grow and finance dozens of drug companies each year. Follow the money they channel into the ...

Gilead Sciences, a Bay Area-headquartered biotech and pharmaceutical company, is laying off 104 workers in Foster City, with ...

Spread the loveThe Durham–Chapel Hill metro area, part of North Carolina’s Research Triangle, is experiencing an unprecedented boom in its biotechnology and life sciences sectors. The region has ...

The facility intends to promote on-site collaboration, co-development, and learning with clients and external innovation ...

China’s leaders believe it must be a tech superpower to “enhance national competitiveness and respond to external risks”. The ...

Spread the loveThe unexpected pause that the globe experienced during the COVID-19 epidemic has increased the relevance of medical experts even more. During this time, the value of biotechnologists ...

We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, we are going to take a look at where Ionis Pharmaceuticals, Inc.

In a significant move towards the liberalization of the healthcare sector, Shanghai's Pudong New Area witnessed the first ...

Nov. 22—23andMe has detailed its plans for Bay Area job cuts, while separate tech company cutbacks have helped to shove the technology industry's current burst of layoffs past the 49,000 mark in the ...

Many companies just iterate indefinitely without ever making progress toward an actual drug,” said one biotech VC on a panel ...

Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...

Gilead Sciences, the Bay Area biotech giant best known for its popular HIV drugs and COVID-19 treatment Remdesivir, is laying off 104 workers from its Foster City headquarters. The company has ...